Literature DB >> 1888165

Increased plasma free tryptophan levels in human cancer: a tumor related effect?

A Cascino1, C Cangiano, F Ceci, F Franchi, T Mineo, M Mulieri, M Muscaritoli, F Rossi Fanelli.   

Abstract

High free tryptophan (F-TRP) plasma levels are found in cancer patients (CP). F-TRP plasma concentrations are affected by the levels of its carrier, albumin (ALB), and free fatty acids (FFA) competing with TRP for ALB binding sites. The lack of correlation between F-TRP, ALB and FFA in CP suggests a tumor-dependent effect on the rise in F-TRP. To verify this hypothesis, F-TRP, ALB and FFA levels were assayed in 12 lung and 16 breast CP susceptible to radical surgery, before and 15 days after surgical removal of the tumor. F-TRP levels significantly decreased after tumor ablation. Since no correlation was found between F-TRP, ALB and FFA variations, it is conceivable that the tumor itself may be responsible for the high F-TRP levels in CP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1888165

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Monitoring Breast Cancer Response to Treatment Using Stokes Shift Spectroscopy of Blood Plasma.

Authors:  Krishnamoorthy Chithra; Prakasarao Aruna; Gnanatheepam Einstein; Srinivasan Vijayaraghavan; Singaravelu Ganesan
Journal:  J Fluoresc       Date:  2019-06-12       Impact factor: 2.217

2.  Chaperon-like Activation of Serum-Inducible Tryptophanyl-tRNA Synthetase Phosphorylation through Refolding as a Tool for Analysis of Clinical Samples.

Authors:  Elena L Paley
Journal:  Transl Oncol       Date:  2011-12-01       Impact factor: 4.243

3.  Kynurenine pathway metabolites in humans: disease and healthy States.

Authors:  Yiquan Chen; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2009-01-08

4.  The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer.

Authors:  Masato Shingyoji; Toshihiko Iizasa; Masahiko Higashiyama; Fumio Imamura; Nobuhiro Saruki; Akira Imaizumi; Hiroshi Yamamoto; Takashi Daimon; Osamu Tochikubo; Toru Mitsushima; Minoru Yamakado; Hideki Kimura
Journal:  BMC Cancer       Date:  2013-02-15       Impact factor: 4.430

5.  An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.

Authors:  Olga Novikov; Zhongyan Wang; Elizabeth A Stanford; Ashley J Parks; Alejandra Ramirez-Cardenas; Esther Landesman; Israa Laklouk; Carmen Sarita-Reyes; Daniel Gusenleitner; Amy Li; Stefano Monti; Sara Manteiga; Kyongbum Lee; David H Sherr
Journal:  Mol Pharmacol       Date:  2016-08-29       Impact factor: 4.436

6.  Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.

Authors:  Gianmaria Miolo; Elena Muraro; Donatella Caruso; Diana Crivellari; Anthony Ash; Simona Scalone; Davide Lombardi; Flavio Rizzolio; Antonio Giordano; Giuseppe Corona
Journal:  Oncotarget       Date:  2016-06-28

7.  Specific urinary metabolites in canine mammary gland tumors.

Authors:  Marcela Valko-Rokytovská; Peter Očenáš; Aneta Salayová; Radka Titková; Zuzana Kostecká
Journal:  J Vet Sci       Date:  2020-03       Impact factor: 1.672

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.